Advanced Search
Contact | Corporate | Help

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors

Sponsors:
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Solid Cancers
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: MPDL3280A
Enrollment:
100

Additional information about NCT01375842.


SourceSolution © 2008-2012